Core Insights - Eastman Chemical Company (EMN) reported fourth-quarter 2025 earnings of 92 cents per share, a decline of approximately 67% from $2.82 in the same quarter last year [1] - Adjusted earnings were 75 cents per share, down from $1.87 year-over-year, and below the Zacks Consensus Estimate of 76 cents [1][10] - Revenues for the fourth quarter were $1,973 million, a decrease of around 12% year-over-year, missing the Zacks Consensus Estimate of $2,037.2 million [2] Financial Performance - The company achieved approximately $100 million in cost savings, surpassing its target of over $75 million for 2025 [3] - Cash and cash equivalents at the end of the quarter were $566 million, down about 32% year-over-year, while net debt increased to $4,221 million, up roughly 1% [8] - Operating cash flow was $502 million for the quarter, a decline of around 7% year-over-year, with nearly $1 billion generated from operating activities in 2025 [8] Segment Performance - Advanced Materials segment sales fell 9% year-over-year to $656 million, missing estimates [4] - Additives & Functional Products segment sales were $662 million, down 5% from the previous year, also missing estimates [5] - Chemical Intermediaries segment sales decreased 17% year-over-year to $418 million, below estimates due to weak market demand [6] - Fibers segment reported sales of $234 million, down 27% year-over-year, but exceeded estimates [7] Guidance and Outlook - For Q1 2026, EMN expects adjusted EPS to be in the range of $1.00-$1.20, driven by volume growth and reduced customer caution [10][14] - The company aims to enhance cost reduction actions to a range of $125-$150 million, building on previous efforts [11] - EMN anticipates improved earnings year-over-year in 2026, supported by innovation, better manufacturing utilization, and favorable currency exchange rates [12] Market Performance - EMN's shares have declined by 30.7% over the past year, compared to a 21.8% decline in the Zacks Chemicals Diversified industry [15]
Eastman Chemical's Q4 Earnings and Sales Lag on Weak Demand